Monocyclic L-nucleosides, analogs and uses thereof
US6642206B2 · kind B2 · utility
85Cited by
17References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2002 |
| Grant date | Nov 4, 2003 |
| Priority date | — |
| Expiry date | Apr 9, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel monocyclic L-Nucleoside compounds have the general formula Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.